Cold-fX

Cold-Fx is a product derived from the roots of North American ginseng. It was formulated by Jacqueline Shan, and originally manufactured by her company, Afexa Life Sciences. Afexa was acquired by Valeant Pharmaceuticals in 2011. Bausch & Lomb, acquired by Valeant, is the marketing company for Cold-Fx, as of 2025.